Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States.
Fair value with mediocre balance sheet.
Share Price & News
How has Evolent Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EVH's share price has been volatile over the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: EVH underperformed the US Healthcare Services industry which returned 13.5% over the past year.
Return vs Market: EVH underperformed the US Market which returned -10% over the past year.
Price Volatility Vs. Market
How volatile is Evolent Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StDoes Evolent Health, Inc. (NYSE:EVH) Have A High Beta?
1 month ago | Simply Wall StEvolent Health, Inc. Just Released Its Full-Year Earnings: Here's What Analysts Think
1 month ago | Simply Wall StShould You Investigate Evolent Health, Inc. (NYSE:EVH) At US$11.56?
Is Evolent Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: EVH ($5.42) is trading below our estimate of fair value ($18.35)
Significantly Below Fair Value: EVH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: EVH is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.
PE vs Market: EVH is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EVH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EVH is good value based on its PB Ratio (0.5x) compared to the US Healthcare Services industry average (3x).
How is Evolent Health forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EVH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EVH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EVH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EVH's revenue (11.3% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: EVH's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EVH's Return on Equity is forecast to be high in 3 years time
How has Evolent Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EVH is currently unprofitable.
Growing Profit Margin: EVH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EVH is unprofitable, and losses have increased over the past 5 years at a rate of -49.3% per year.
Accelerating Growth: Unable to compare EVH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EVH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (23.3%).
Return on Equity
High ROE: EVH has a negative Return on Equity (-32.89%), as it is currently unprofitable.
How is Evolent Health's financial position?
Financial Position Analysis
Short Term Liabilities: EVH's short term assets ($228.8M) exceed its short term liabilities ($192.8M).
Long Term Liabilities: EVH's short term assets ($228.8M) do not cover its long term liabilities ($376.2M).
Debt to Equity History and Analysis
Debt Level: EVH's debt to equity ratio (31.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if EVH's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EVH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if EVH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Evolent Health's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EVH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate EVH's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EVH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EVH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EVH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Frank Williams (52yo)
Mr. Frank John Williams co-founded Evolent Health, Inc. in 2011 and serves as its Chief Executive Officer since August 2011. Mr. Williams is a Director at Business Talent Group, LLC and Peer Health Exchang ...
CEO Compensation Analysis
Compensation vs Market: Frank's total compensation ($USD3.31M) is above average for companies of similar size in the US market ($USD2.18M).
Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.
|Co-Founder & COO||9.25yrs||US$1.09m||0.031% $144.0k|
|Chief Legal Officer||4.17yrs||US$636.00k||0.024% $108.6k|
|Executive Vice President of Corporate Performance||0.75yr||US$1.01m||0.018% $83.2k|
|Chief Financial Officer||0.75yr||no data||0.11% $525.3k|
|VP, Chief Accounting Officer & Corporate Controller||4.58yrs||no data||0.016% $71.8k|
|Investor Contact||no data||no data||no data|
|VP & Chief Compliance Officer||3.67yrs||no data||no data|
Experienced Management: EVH's management team is considered experienced (4.2 years average tenure).
|Director||no data||no data||no data|
|Presiding Director||no data||US$195.00k||0.025% $115.4k|
|Independent Director||4yrs||US$175.00k||0.063% $288.4k|
|Independent Director||4.42yrs||US$175.00k||0.017% $80.2k|
|Independent Director||4.58yrs||US$175.00k||0.030% $135.9k|
|Independent Director||2.58yrs||US$175.00k||0.014% $65.8k|
Experienced Board: EVH's board of directors are considered experienced (4.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.
Evolent Health, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Evolent Health, Inc.
- Ticker: EVH
- Exchange: NYSE
- Founded: 2011
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$459.196m
- Shares outstanding: 84.72m
- Website: https://www.evolenthealth.com
Number of Employees
- Evolent Health, Inc.
- 800 North Glebe Road
- Suite 500
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EVH||NYSE (New York Stock Exchange)||Yes||Class A Common Stock||US||USD||Jun 2015|
|9EH||DB (Deutsche Boerse AG)||Yes||Class A Common Stock||DE||EUR||Jun 2015|
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/04/08 09:21|
|End of Day Share Price||2020/04/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.